Literature DB >> 11832214

Autoinhibition of c-Abl.

Helma Pluk1, Karel Dorey, Giulio Superti-Furga.   

Abstract

Despite years of investigation, the molecular mechanism responsible for regulation of the c-Abl tyrosine kinase has remained elusive. We now report inhibition of the catalytic activity of purified c-Abl in vitro, demonstrating that regulation is an intrinsic property of the molecule. We show that the interaction of the N-terminal 80 residues with the rest of the protein mediates autoregulation. This N-terminal "cap" is required to achieve and maintain inhibition, and its loss turns c-Abl into an oncogenic protein and contributes to deregulation of BCR-Abl.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11832214     DOI: 10.1016/s0092-8674(02)00623-2

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  72 in total

1.  Autoinhibition of Jak2 tyrosine kinase is dependent on specific regions in its pseudokinase domain.

Authors:  Pipsa Saharinen; Mauno Vihinen; Olli Silvennoinen
Journal:  Mol Biol Cell       Date:  2003-04       Impact factor: 4.138

2.  Cbl-ArgBP2 complex mediates ubiquitination and degradation of c-Abl.

Authors:  Philippe Soubeyran; Ana Barac; Iwona Szymkiewicz; Ivan Dikic
Journal:  Biochem J       Date:  2003-02-15       Impact factor: 3.857

3.  c-Abl antagonizes the YAP oncogenic function.

Authors:  R Keshet; J Adler; I Ricardo Lax; M Shanzer; Z Porat; N Reuven; Y Shaul
Journal:  Cell Death Differ       Date:  2014-10-31       Impact factor: 15.828

4.  Two distinct phosphorylation pathways have additive effects on Abl family kinase activation.

Authors:  Keith Q Tanis; Darren Veach; Henry S Duewel; William G Bornmann; Anthony J Koleske
Journal:  Mol Cell Biol       Date:  2003-06       Impact factor: 4.272

5.  Angiotensin-II and MARCKS: a hydrogen peroxide- and RAC1-dependent signaling pathway in vascular endothelium.

Authors:  Hermann Kalwa; Juliano L Sartoretto; Simone M Sartoretto; Thomas Michel
Journal:  J Biol Chem       Date:  2012-07-06       Impact factor: 5.157

6.  Kinase domain mutants of Bcr-Abl exhibit altered transformation potency, kinase activity, and substrate utilization, irrespective of sensitivity to imatinib.

Authors:  Ian J Griswold; Mary MacPartlin; Thomas Bumm; Valerie L Goss; Thomas O'Hare; Kimberly A Lee; Amie S Corbin; Eric P Stoffregen; Caitlyn Smith; Kara Johnson; Erika M Moseson; Lisa J Wood; Roberto D Polakiewicz; Brian J Druker; Michael W Deininger
Journal:  Mol Cell Biol       Date:  2006-08       Impact factor: 4.272

7.  Structure, regulation, signaling, and targeting of abl kinases in cancer.

Authors:  Oliver Hantschel
Journal:  Genes Cancer       Date:  2012-05

8.  Activation of abl family kinases in solid tumors.

Authors:  Sourik S Ganguly; Rina Plattner
Journal:  Genes Cancer       Date:  2012-05

9.  Abl N-terminal cap stabilization of SH3 domain dynamics.

Authors:  Shugui Chen; Teodora Pene Dumitrescu; Thomas E Smithgall; John R Engen
Journal:  Biochemistry       Date:  2008-05-02       Impact factor: 3.162

10.  Extracellular vesicle-mediated transfer of donor genomic DNA to recipient cells is a novel mechanism for genetic influence between cells.

Authors:  Jin Cai; Yu Han; Hongmei Ren; Caiyu Chen; Duofen He; Lin Zhou; Gilbert M Eisner; Laureano D Asico; Pedro A Jose; Chunyu Zeng
Journal:  J Mol Cell Biol       Date:  2013-04-11       Impact factor: 6.216

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.